Evidence map›Paper›PMID 30301163›Full record

ArticleCancers2018

Unliganded Progesterone Receptor Governs Estrogen Receptor Gene Expression by Regulating DNA Methylation in Breast Cancer Cells.

Gaetano Verde, Lara I De Llobet, Roni H G Wright, Javier Quilez, Sandra Peiró, François Le Dily, Miguel Beato

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Night Shift Work, DNA Methylation and Telomere Length: An Investigation on Hospital Female Nurses.International journal of environmental research and public health · 2019
    Article
  13. Review
  14. Article
  15. Signaling by Steroid Hormones in the 3D Nuclear Space.International journal of molecular sciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Gaetano VerdeGene Regulation, Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Doctor Aiguader 88, 08003 Barcelona, Spain. gverde@uic.es.ORCID 0000-0003-4768-0165
Lara I De LlobetGene Regulation, Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Doctor Aiguader 88, 08003 Barcelona, Spain. lara.llobet@crg.eu.ORCID 0000-0001-6249-7276
Roni H G WrightGene Regulation, Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Doctor Aiguader 88, 08003 Barcelona, Spain. roni.wright@crg.eu.ORCID 0000-0001-6249-7276
Javier QuilezGene Regulation, Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Doctor Aiguader 88, 08003 Barcelona, Spain. javier.quilez@crg.eu.
Sandra PeiróVall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. speiro@vhio.net.ORCID 0000-0001-9519-3877
François Le DilyGene Regulation, Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Doctor Aiguader 88, 08003 Barcelona, Spain. francois.ledily@crg.eu.ORCID 0000-0002-8324-7927
Miguel BeatoGene Regulation, Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Doctor Aiguader 88, 08003 Barcelona, Spain. miguel.beato@crg.eu.
Centre for Genomic Regulation · ESUniversitat Pompeu Fabra · ESVall d'Hebron Institute of Oncology · ES

Funding

European Molecular Biology Organization ALTF 1106-2011Generalitat de Catalunya CERCA ProgrammeMinisterio de Ciencia y Tecnología Centro de Excelencia Severo Ochoa 2013-2017Ministerio de Ciencia y Tecnología IJCI-2014-20723Ministerio de Ciencia y Tecnología : SAF 2013-42497-PSeventh Framework Programme 299429
6 · The paper itself

Abstract

Breast cancer prognosis and response to endocrine therapy strongly depends on the expression of the estrogen and progesterone receptors (ER and PR, respectively). Although much is known about ERα gene (

Indexed as

breast cancerDNA methylationendocrine therapyestrogen receptorgene expressionprogesterone receptor

Identifiers

PMID30301163
PMCPMC6210734
OpenAlexW2894822441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.